Gemnelatinib is a tyrosine kinase inhibitor (WO2018077227, implementation example 1). Gemnelatinib can be used for the research of cancer[1].
Gemnelatinib is a tyrosine kinase inhibitor[1]
[1]. WO2018077227
Gemnelatinib is a tyrosine kinase inhibitor (WO2018077227, implementation example 1). Gemnelatinib can be used for the research of cancer[1].
Gemnelatinib is a tyrosine kinase inhibitor[1]
[1]. WO2018077227